Associated Papers
Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Blons H et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2004
Select a paper to view details